GLP Weekly: New look at debunked study claiming glyphosate increases cancer risk; Assessing coronavirus coverage - Too late, too alarmist?; and more!

GLP Features Articles by GLP staff and contributors

Assessing coronavirus media coverage: Too late, too alarmist, and too much censorship Andrew Porterfield Remember the questionable study claiming glyphosate boosts cancer risk 41%? Lead author reasserts her claim, EPA refutes it, and we take a second look Geoffrey Kabat Searching for the ‘big break’ that could turn stem cells into a weapon against dementia Sam Moxon Viewpoint: We can sustainably feed 10 billion people. Here’s how CRISPR and GMO crops can help Rupesh Paudyal Gene therapy shows success against some cancers and inherited disorders. Can it tackle obesity? Cameron English Gene drives could revolutionize how we deal with pests—if the technology avoids the controversial fate of GMOs Andrew Porterfield Why the UK wants to share everything it knows about the genetics of 500,000 Britons David Adam Podcast: Tackling ethical questions about CRISPR with GLP’s groundbreaking Global Gene Editing Regulation Tracker and Index Bernadine Strik, Jon Entine, Kayleen Schreiber, Kevin Folta Viewpoint: Glyphosate causes kidney disease? Debunking anti-GMO activist Vandana Shiva’s herbicide junk science Alison Van Eenennaam Examining our history of advertising for OxyContin and other opioids: Have we learned enough about the dangers of addiction? Pamela Zuber